Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

[Full Text]
Displaying Investigations 1 to 32 of 32 found
From 18 References


Biggerstaff et al 2006, Leukemia
  Myelodysplastic syndrome, NOS
KMT2A/ELL
t(11;19)(q23;p13)
  Acute monoblastic leukemia with differentiation (FAB type M5b)
KMT2A/ELL
t(11;19)(q23;p13)
  Chronic myeloproliferative disorder, NOS
KMT2A/ELL
t(11;19)(q23;p13)

Chen et al 2018, Proc Natl Acad Sci U S A
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A/ELL
t(11;19)(q23;p13)
T-Lineage

De Braekeleer et al 2009, Ann Hematol
  Acute monoblastic leukemia (FAB type M5)
KMT2A/ELL
t(1;19;11)(p36;p13;q23)

De Braekeleer et al 2011, Mol Oncol
  Acute monoblastic leukemia with differentiation (FAB type M5b)
KMT2A/ELL
t(11;19)(q23;p13)

Hu et al 2018, Nucleic Acids Res
  Adenocarcinoma Breast
ELL/INSR
t(19;19)(p13;p13)
  Malignant epithelial tumor, special type Uterus, corpus
ELL/ARL4D
t(17;19)(q21;p13)
  Benign epithelial tumor, special type Thyroid
ELL/FKBP8
t(19;19)(p13;p13)
  Squamous cell carcinoma Lung
ELL/LDLRAD1
t(1;19)(p32;p13)
  Adenocarcinoma Oesophagus
ELL/MKNK2
t(19;19)(p13;p13)
  Benign epithelial tumor, special type Thyroid
ELL/RABGGTA
t(14;19)(q12;p13)
  Adenocarcinoma Uterus, corpus
ZNF709/ELL
t(19;19)(p13;p13)

Kakihana et al 2008, Cancer Genet Cytogenet
  Chronic myelomonocytic leukemia
KMT2A/ELL
t(11;19)(q23;p13)

Kanda et al 1997, Int J Hematol
  Acute myeloid leukemia, NOS
KMT2A/ELL
t(11;19)(q23;p13)

Liu et al 2017, Nat Genet
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A/ELL
t(11;19)(q23;p13)
T-Lineage

McPherson et al 2011, PLoS Comput Biol
  Adenocarcinoma Ovary
ELL/CLIP2
t(7;19)(q11;p13)

Meyer et al 2013, Leukemia
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A/ELL
t(11;19)(q23;p13)

Mitani et al 1995, Blood
  Acute myeloid leukemia, NOS
KMT2A/ELL
t(11;19)(q23;p13)
  Acute monoblastic leukemia (FAB type M5)
KMT2A/ELL
t(11;19)(q23;p13)

Moorman et al 1998, Leukemia
  Refractory anemia with excess of blasts (FAB)
KMT2A/ELL
t(11;19)(q23;p13)

Shih et al 2006, Leukemia
  Acute monoblastic leukemia (FAB type M5)
KMT2A/ELL
t(11;19)(q23;p13)

Strehl et al 2001, Blood
  Acute myeloblastic leukemia with maturation (FAB type M2)
KMT2A/ELL
t(11;19)(q23;p13)

Thirman et al 1994, Proc Natl Acad Sci U S A
  Acute myelomonocytic leukemia (FAB type M4)
KMT2A/ELL
t(11;19)(q23;p13)

Turkmen et al 2012, Genes Chromosomes Cancer
  Bilineage or biphenotypic leukemia
KMT2A/ELL
t(11;19)(q23;p13)

Yamamoto et al 2002, Cancer Genet Cytogenet
  Acute myelomonocytic leukemia (FAB type M4)
KMT2A/ELL
t(11;19)(q23;p13)

Yoshihara et al 2015, Oncogene
  Squamous cell carcinoma Lung
ELL/CRLF1
t(19;19)(p13;p13)
  Adenocarcinoma Lung
ELL/MVB12A
t(19;19)(p13;p13)
  Adenocarcinoma Lung
CDC37/ELL
t(19;19)(p13;p13)
  Adenocarcinoma Kidney
ELL/CISD3
t(17;19)(q12;p13)
  Acute myeloid leukemia, NOS
KMT2A/ELL
t(11;19)(q23;p13)
  Adenocarcinoma Breast
ELL/SMIM7
t(19;19)(p13;p13)